A Review of Pain Control in Pediatric Cardiac Bypass Surgery
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Introduction

Current Pain Control Protocol

Currently, children undergoing cardiac surgery with
cardiopulmonary bypass receive inhalation anesthetics
and high dose synthetic opioids, such as fentanyl, to
reduce the neurohormonal stress and hemodynamic
changes due to surgery. Fentanyl is a rapid-acting, highly
potent analgesic, however, adverse effects include:
respiratory depression, bradycardia, post-operative
nausea and vomiting, and opioid tolerance. In addition, the
short half-life of fentanyl requires several boluses to be
administered throughout the course of the surgery
resulting in fluctuating levels of opioids and pain control.
Several strategies to advance pain control incorporate
regional and neuraxial anesthetic techniques, but the risks
of anticoagulation preclude routine use. Alternatively using
a longer half-life drug, such as methadone, for analgesia
during cardiac surgery decreases the need for several
boluses to be administered and has been suggested to
reduce the post-operative adverse effects usually
associated with opioids.
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In this study, the opioid requirements during the first 24
hour post-operative period for children who have
undergone cardiac surgery and received intraoperative
fentanyl were recorded and analyzed. The average
morphine requirement in the first 24 hour postoperative
period was 0.363 mg/kg, a considerable amount, which
reveals a need to explore alternative, long-lasting options
for intraoperative analgesia such as methadone.

There were 64 cardiac surgery patients (mean age
4.3±1.7, mean weight 17.1±7.5 kg) who received
between 10-30mcg/kg of fentanyl, the mean total dose of
morphine in the first 24-hour postoperative period was
0.363mg/kg, with a standard deviation of 0.239.
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The data from this internal case review of pain control in
pediatric cardiac bypass surgery will be used delineate
the appropriate sample size for studying postoperative
pain control. This is applicable to our study that
compares intraoperatively administered fentanyl to
methadone on postoperative opioid requirement. This
internal case review of 64 cardiac surgery patients (mean
age 4.3±1.7, mean weight 17.1±7.5 kg) receiving
between 10-30 mcg/kg of fentanyl showed a mean total
dose of morphine in the first 24-hour postoperative period
was 0.363 mg/kg, with a standard deviation of 0.239.
Assuming no difference between the two treatment
strategies in the population, a total sample size of 76 in
each group will provide 80% power to detect a difference
of 0.109 in means, using a two-sample t-test at the 0.05
significance level. The high amount of postoperative
morphine required, as determined by this study, reveals
the need to find alternative pain control strategies such
as opioids with longer half-lives and regional techniques.
Exploring the effectiveness of methadone, a long acting
opioid, to reduce postoperative adverse effects is an area
of future study.
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Electronic medical records were retrospectively reviewed for 64 pediatric patients following cardiac bypass surgery at Children’s
National Health System from June of 2014 through February of 2016. Inclusion criteria included: age between 1 and 18 years,
weight greater than 6 kg, American Society of Anesthesiologists (ASA) status of ASA I, II, or III, and those who received
intraoperative fentanyl. Exclusion criteria included: personal or family history of malignant hyperthermia, personal history of hepatic
disorders, history of chronic nausea or vomiting, history of pulmonary hypertension, emergency cardiac surgery, respiratory
dysfunction, or requirement of supplemental oxygen therapy, history of opioid abuse, addiction or tolerance, allergic reaction to
opioids, obesity, and perioperative use of inotropic agents or pacemaker. Intraoperative and postoperative opioid class and dose
was recorded for all patients. The data was compiled and analyzed to obtain a mean and standard deviation for future study.
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